124 related articles for article (PubMed ID: 38117565)
21. Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions.
Zhou H; Mody RR; Luna E; Armylagos D; Xu J; Schwartz MR; Mody DR; Ge Y
Cancer Cytopathol; 2016 May; 124(5):317-23. PubMed ID: 26774025
[TBL] [Abstract][Full Text] [Related]
22. High-risk HPV testing vs liquid-based cytology for cervical cancer screening among 25- to 30-year-old women: A historical cohort study.
Feldstein O; Gali-Zamir H; Schejter E; Feinberg T; Yehuda-Shnaidman E; Bornstein J; Levy T
Acta Obstet Gynecol Scand; 2023 Feb; 102(2):226-233. PubMed ID: 36478537
[TBL] [Abstract][Full Text] [Related]
23. The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinic.
Fox PA; Seet JE; Stebbing J; Francis N; Barton SE; Strauss S; Allen-Mersh TG; Gazzard BG; Bower M
Sex Transm Infect; 2005 Apr; 81(2):142-6. PubMed ID: 15800092
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions.
Cuzick J; Thomas Cox J; Zhang G; Einstein MH; Stoler M; Trupin S; Behrens CM
Int J Cancer; 2013 Feb; 132(4):959-66. PubMed ID: 22806936
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of abnormal anal cytology and high-grade squamous intraepithelial lesions among a cohort of HIV-infected men who have sex with men.
Sendagorta E; Herranz P; Guadalajara H; Bernardino JI; Viguer JM; Beato MJ; García-Olmo D; Peña JM
Dis Colon Rectum; 2014 Apr; 57(4):475-81. PubMed ID: 24608304
[TBL] [Abstract][Full Text] [Related]
26. The performance of anal cytology as a screening test for anal HSILs in homosexual men.
Jin F; Grulich AE; Poynten IM; Hillman RJ; Templeton DJ; Law CL; Farnsworth A; Garland SM; Fairley CK; Roberts JM;
Cancer Cytopathol; 2016 Jun; 124(6):415-24. PubMed ID: 26915346
[TBL] [Abstract][Full Text] [Related]
27. Colposcopy referral rate can be reduced by high-risk human papillomavirus triage in the management of recurrent atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion cytology in Finland.
Jakobsson M; Tarkkanen J; Auvinen E; Häkkinen R; Laurila P; Tapper AM
Int J STD AIDS; 2012 Jul; 23(7):485-9. PubMed ID: 22844002
[TBL] [Abstract][Full Text] [Related]
28. Importance of anal cytology and screening for anal dysplasia in individuals living with HIV with an emphasis on women.
Cimic A; Wilkin TJ; Heymann JJ; Alperstein S; Ellsworth G; Siddiqui MT
Cancer Cytopathol; 2019 Jun; 127(6):407-413. PubMed ID: 31145557
[TBL] [Abstract][Full Text] [Related]
29. Risk of vulvar, vaginal and anal high-grade intraepithelial neoplasia and cancer according to cervical human papillomavirus (HPV) status: A population-based prospective cohort study.
Bertoli HK; Thomsen LT; Iftner T; Dehlendorff C; Kjær SK
Gynecol Oncol; 2020 May; 157(2):456-462. PubMed ID: 32008794
[TBL] [Abstract][Full Text] [Related]
30. Comparison of HPV and cytology triage algorithms for women with borderline or mild dyskaryosis in population-based cervical screening (VUSA-screen study).
Rijkaart DC; Berkhof J; van Kemenade FJ; Rozendaal L; Verheijen RH; Bulk S; Herreilers ME; Verweij WM; Snijders PJ; Meijer CJ
Int J Cancer; 2010 May; 126(9):2175-81. PubMed ID: 19739071
[TBL] [Abstract][Full Text] [Related]
31. Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.
Aoyama-Kikawa S; Fujita H; Hanley SJB; Kasamo M; Kikuchi K; Torigoe T; Matsuno Y; Tamakoshi A; Sasaki T; Matsuura M; Kato Y; Dong P; Watari H; Saito T; Sengoku K; Sakuragi N
Cancer Sci; 2018 Jun; 109(6):2003-2012. PubMed ID: 29660849
[TBL] [Abstract][Full Text] [Related]
32. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
33. A systematic review and meta-analysis of cytology and HPV-related biomarkers for anal cancer screening among different risk groups.
Clarke MA; Deshmukh AA; Suk R; Roberts J; Gilson R; Jay N; Stier EA; Wentzensen N
Int J Cancer; 2022 Dec; 151(11):1889-1901. PubMed ID: 35793241
[TBL] [Abstract][Full Text] [Related]
34. Negative Predictive Value of Human Papillomavirus Testing: Implications for Anal Cancer Screening in People Living with HIV/AIDS.
Wang Y; Wang Y; Gaisa MM; Sigel K; Zheng W; Liu Y; Wang Y
J Oncol; 2020; 2020():6352315. PubMed ID: 32411239
[TBL] [Abstract][Full Text] [Related]
35. HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications.
Rijkaart DC; Berkhof J; van Kemenade FJ; Coupe VM; Rozendaal L; Heideman DA; Verheijen RH; Bulk S; Verweij W; Snijders PJ; Meijer CJ
Br J Cancer; 2012 Feb; 106(5):975-81. PubMed ID: 22251922
[TBL] [Abstract][Full Text] [Related]
36. The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study.
Tidy JA; Lyon R; Ellis K; Macdonald M; Palmer JE
BJOG; 2020 Sep; 127(10):1260-1267. PubMed ID: 32279427
[TBL] [Abstract][Full Text] [Related]
37. Neovaginal and Anal High-Risk Human Papillomavirus DNA Among Thai Transgender Women in Gender Health Clinics.
Uaamnuichai S; Panyakhamlerd K; Suwan A; Suwajo P; Phanuphak N; Ariyasriwatana C; Janamnuaysook R; Teeratakulpisarn N; Vasuratna A; Taechakraichana N
Sex Transm Dis; 2021 Aug; 48(8):547-549. PubMed ID: 33534409
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of optical coherence tomography in the triage of women with minor abnormal cervical cytology before colposcopy.
Yan L; Xiao X; He L; Shi L; Yang X; Zhang J; Zhang Y; Fu C
PLoS One; 2023; 18(3):e0282833. PubMed ID: 36913396
[TBL] [Abstract][Full Text] [Related]
39. Primary HPV screening for cervical cancer: Results after two screening rounds in a regional screening program in Finland.
Veijalainen O; Kares S; Kotaniemi-Talonen L; Kujala P; Vuento R; Luukkaala T; Kholová I; Mäenpää J
Acta Obstet Gynecol Scand; 2021 Mar; 100(3):403-409. PubMed ID: 33037625
[TBL] [Abstract][Full Text] [Related]
40. Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women.
Luttmer R; Berkhof J; Dijkstra MG; van Kemenade FJ; Snijders PJ; Heideman DA; Meijer CJ
J Clin Virol; 2015 Jun; 67():59-66. PubMed ID: 25959161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
